Tekla Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-345,050
Closed -$3.33M 155
2017
Q2
$3.33M Hold
345,050
0.12% 95
2017
Q1
$2.05M Hold
345,050
0.08% 112
2016
Q4
$1.36M Hold
345,050
0.06% 119
2016
Q3
$3.62M Hold
345,050
0.14% 96
2016
Q2
$5.03M Buy
345,050
+104,100
+43% +$1.78M 0.21% 86
2016
Q1
$4.64M Sell
240,950
-34,050
-12% -$688K 0.2% 89
2015
Q4
$6.64M Hold
275,000
0.24% 78
2015
Q3
$6.75M Buy
+275,000
New +$7.79M 0.24% 89

Other funds holding DVAX

Tekla Capital Management's DVAX Position: Q3 2017 in Review

Tekla Capital Management sold out of Dynavax Technologies (DVAX) in Q3 2017, closing a stake of 345,050 shares — an estimated $3.33M sold.

Tekla Capital Management first reported a position in DVAX in Q3 2015 and held it in 8 quarters. The position peaked at $6.75M in Q3 2015. 119 funds tracked by Wall St. Rank hold DVAX as of Q3 2017.

  • Tekla Capital Management reported no remaining Dynavax Technologies position as of Q3 2017 after selling out during the quarter.
  • Tekla Capital Management sold 345,050 Dynavax Technologies shares in Q3 2017, an estimated $3.33M.
  • Tekla Capital Management first reported a position in Dynavax Technologies in Q3 2015 and held it in 8 quarters.
  • Tekla Capital Management's Dynavax Technologies position peaked at $6.75M in Q3 2015.
  • 119 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2017.

Based on Tekla Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.